Literature DB >> 11673210

Influence of preservation solution on early graft failure in clinical lung transplantation.

G Thabut1, I Vinatier, O Brugière, G Lesèche, P Loirat, A Bisson, J Marty, M Fournier, H Mal.   

Abstract

The aim of this study was to assess the influence of preservation solution type and extra- or intracellular composition on the occurrence of early graft dysfunction after clinical lung transplantation. For 170 patients who underwent a single (n = 124) or bilateral (n = 46) lung transplantation in two centers in Paris between 1988 and 1999, the preservation technique applied to the donor lung was single-flush perfusion of the pulmonary artery with one of several solutions of intracellular (Euro-Collins, n = 61; University of Wisconsin, n = 24) or extracellular composition (Cambridge, n = 64; Celsior, n = 21). The early postoperative outcome of these patients was reviewed. Reimplantation edema occurred in 48% of all patients, and the overall 1-mo survival rate was 84%. No significant difference in the incidence of edema, duration of mechanical ventilation, and 1-mo survival rate was observed between the four groups or between intra- and extracellular groups. After adjustment for graft ischemic time by means of multivariate analysis, the use of extracellular preservation fluid was associated with a lower incidence of reimplantation edema without effect on 1-mo mortality. Graft ischemic time was associated with both edema occurrence and 1-mo survival rate (p = 0.02 and p = 0.01, respectively). We conclude that extracellular-type solutions are associated with better lung preservation than intracellular-type solutions in clinical transplantation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11673210     DOI: 10.1164/ajrccm.164.7.2012135

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  13 in total

Review 1.  Preservation solution for lung transplantation.

Authors:  Yoshinori Okada; Takashi Kondo
Journal:  Gen Thorac Cardiovasc Surg       Date:  2009-12

2.  Risk factors and outcome of primary graft dysfunction after lung transplantation in Korea.

Authors:  Sungwoo Moon; Moo Suk Park; Jin Gu Lee; Ji Ye Jung; Young Ae Kang; Young Sam Kim; Se Kyu Kim; Joon Chang; Hyo Chae Paik; Song Yee Kim
Journal:  J Thorac Dis       Date:  2016-11       Impact factor: 2.895

3.  Celsior versus University of Wisconsin preserving solutions for liver transplantation: postreperfusion syndrome and outcome of a 5-year prospective randomized controlled study.

Authors:  Francisco A García-Gil; María T Serrano; Lorena Fuentes-Broto; Juan Arenas; José J García; Antonio Güemes; Vanesa Bernal; Ana Campillo; Carlos Sostres; Juan J Araiz; Pablo Royo; Miguel A Simón
Journal:  World J Surg       Date:  2011-07       Impact factor: 3.352

Review 4.  Evaluation and Management of the Potential Lung Donor.

Authors:  Andrew Courtwright; Edward Cantu
Journal:  Clin Chest Med       Date:  2017-08-31       Impact factor: 2.878

Review 5.  Shear stress-related mechanosignaling with lung ischemia: lessons from basic research can inform lung transplantation.

Authors:  Shampa Chatterjee; Gary F Nieman; Jason D Christie; Aron B Fisher
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2014-09-19       Impact factor: 5.464

Review 6.  Preservation solutions for cardiac and pulmonary donor grafts: a review of the current literature.

Authors:  Nicholas Latchana; Joshua R Peck; Bryan Whitson; Sylvester M Black
Journal:  J Thorac Dis       Date:  2014-08       Impact factor: 2.895

Review 7.  Procurement of lungs from brain-dead donors.

Authors:  Prasad Krishnan; Sahar-Al-Sadat Sahar Saddoughi
Journal:  Indian J Thorac Cardiovasc Surg       Date:  2021-03-19

8.  Pancreas preservation for pancreas and islet transplantation.

Authors:  Yasuhiro Iwanaga; David Er Sutherland; James V Harmon; Klearchos K Papas
Journal:  Curr Opin Organ Transplant       Date:  2008-08       Impact factor: 2.640

9.  Anti-type V collagen humoral immunity in lung transplant primary graft dysfunction.

Authors:  Takekazu Iwata; Alexander Philipovskiy; Amanda J Fisher; Robert G Presson; Masako Chiyo; Jae Lee; Elizabeth Mickler; Gerald N Smith; Irina Petrache; David B Brand; William J Burlingham; Bagavathi Gopalakrishnan; Daniel S Greenspan; Jason D Christie; David S Wilkes
Journal:  J Immunol       Date:  2008-10-15       Impact factor: 5.422

10.  Risk factors for reperfusion injury after lung transplantation.

Authors:  Silvia R Cottini; Nicolas Lerch; Marc de Perrot; Miriam M Treggiari; Anastase Spiliopoulos; Laurent Nicod; Bara Ricou
Journal:  Intensive Care Med       Date:  2006-03-07       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.